Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Employment test 11 - 50 employees
Company dna cabinet ores
operating since 1972
906.73
Headquarter in Paris
active in Legal Services, IP Consulting, and Matchmaking and Trading

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Elsa Martin-Touaux has worked on the following 5 EPO patent applications which have been published in the last five years:

EP12305332

A mixture of polar glycolipids for use in the treatment of pain and COPD

IPC classification:
A61K 31/739, A61K 35/74, A61P 11/00, A61P 29/00, C08B 37/00, C12P 19/04, C12R 1/89
Applicant:
Sanofi, S.A.
Agent:
Elsa Martin-Touaux, Sanofi
Status:
APPLICATION WITHDRAWN
EP12305677

CHO expression system

IPC classification:
C12N 15/69, C12N 15/79
Applicant:
Sanofi, S.A.
Agent:
Elsa Martin-Touaux, Sanofi
Status:
APPLICATION WITHDRAWN
EP11719346

ROBO1-FC FUSION PROTEIN AND USE THEREOF FOR TREATING TUMOURS

IPC classification:
A61K 38/00, C07K 14/475
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Elsa Martin-Touaux, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13843154

MODULATION OF RNA ACTIVITY AND VASCULAR PERMEABILITY

IPC classification:
A61K 31/7088, A61K 48/00, A61P 7/10, A61P 9/00, A61P 35/00, C12N 15/113
Applicant:
University of Sydney
Agent:
Elsa Martin-Touaux, Cabinet Orès
Agent:
Elsa Martin-Touaux, Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP11802949

ROBO1-FC FUSION PROTEIN FOR USE IN THE TREATMENT OF HEPATOCARCINOMA

IPC classification:
A61K 38/18, C07K 14/475
Applicant:
Sanofi, S.A.
Agent:
Gaëlle Jan, Cabinet Lavoix
Agent:
Elsa Martin-Touaux, Sanofi
Status:
PATENT GRANTED

Please Sign in to use this feature